The Latest "Buzz on the Street" Show: Featuring AREV Brands International (CSE: AREV) Coverage | Financial Buzz

The Latest “Buzz on the Street” Show: Featuring AREV Brands International (CSE: AREV) (OTC: AREVF) Coverage’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “AREV International Brands Ltd. Announces Focus and Roll Out in California.”

AREV Brands International Ltd. (CSE: AREV) announced it has entered into a Binding LOI with LB Anaheim Street LLC, a company organized under the laws of California, USA (“Anaheim”) and LBC Integrated Growers LLC, a company organized under the laws of California

AREV Brands International Ltd. produces and delivers functional compounds and ingredients from its world-class extraction systems. AREV is revolutionizing the current delivery method of terpenes, cannabinoids and flavonoids. These premium ingredients and formulations are used in products targeted for sale in the natural health, medical, functional food, nutraceutical, sport nutrition and bioceutical markets. AREV innovates through extraction to produce extracts from specific selected plant and exude from trees that address 5 areas of health including Anxiety, Pain Management, Insomnia, Central Nervous System Disorders & Libido.

Following Canada’s legalization of cannabis, as well as the U.S.’s ongoing efforts, cannabis-based companies have seen their revenues grow substantially over the past few years. Last year, the North American region reached several historic milestones within the cannabis industry. Perhaps most notably, Canada’s legalization of cannabis was a major event that reshaped the marketplace as the country became the first and only G-7 nation to legalize cannabis, however, several of the other G-7 nations have since followed suit and implemented a partial or full medicinal cannabis legislation. The widespread legalization movement is now causing a growing demand around the world for both medical and recreational cannabis applications. Moreover, the demand is prompting cannabis companies to ramp up operations in order to meet this demand. As a result, cannabis companies are seeing tremendous revenue growth as the cannabis marketplace begins to take off. Nevertheless, the market is heavily hindered by the lack of clinical trials evaluating cannabis and its efficacy., even though despite the lack of research, the industry has already made significant progress in recent years. For instance, the U.S. Drug Enforcement Agency delisted CBD from its Schedule 1 listing. Shortly after the DEA’s decision, the U.S. passed the Farm Bill, which legalized hemp. Overall, the U.S. government’s decision to soften its cannabis regulatory laws highlights the major steps the industry has taken. Moreover, as cannabis research continues, more countries are expected to adopt medicinal cannabis legislation. On the other hand, the recreational market is continuing to thrive, largely due to the U.S. and Canadian markets continuously expanding. According to data compiled by MarketsandMarkets research, the global cannabis market is projected to grow from USD 10.3 Billion in 2018 to USD 39.4 Billion by 2023. Additionally, the market is expected to register a CAGR of 30.7% during the forecast period. 

Primarily, the majority of the cannabis revenue currently stems from medicinal sales. However, it is projected that the recreational sector will overshadow the medical sector within the next several years. For instance, In the second quarter of 2017, California’s flower sales accounted for 55% of its total cannabis sales. Then,, in 2018, California witnessed its flower sales decline by 3% in the first quarter. Moreover, 67% of Colorado’s cannabis sales were made up of flower when legal sales began back in 2014. Now, flower only accounts for 44% of Colorado’s total sales. During the same period, Colorado’s concentrates sales more than doubled to 31%, according to BDS Analytics. Consumers are beginning to prefer concentrates and extracts over flower because of the health benefits and more potent effects. On an international-scale, a handful of countries have banned smoking cannabis, but allow vaping. Aaron Salz, Founder of the Stoic Advisory consulting firm in Toronto, says a large export opportunity exists because other countries are modeling their programs after Canada, according to Marijuana Business Daily. “Most countries are choosing to first legalize cannabis oil over flower,” he said. “So that’s created an opportunity for exports to countries that are starting with strict medical regimes with limited qualifying conditions.”

For more information, please visit: AREV Brands International Ltd.

For more corporate news on AREV Brands International Ltd., check out the Buzz on the Street

About Buzz on the Street: One of’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.

Sponsored Content Release. Click for Full Disclosure

  • Sponsored Content Release, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, creates 100% unique original content. also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.

    Please Note: is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on (the ‘Site’) is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content),, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. receives fees for producing and presenting high quality and sophisticated content on along with other financial news PR media services. does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For arev brands international ltd. financial and corporate news dissemination, has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. will always disclose any compensation in securities or cash payments for financial news PR advertising. does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security., members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: